XML 27 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net loss $ (3,808,978) $ (2,686,128)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 195,377 181,047
Warrant market adjustment 652,025 278,044
Share based compensation 841,612 69,309
Loss on impairment of fixed asset 50,666
Bad debts 156,636 43,350
Change in assets and liabilities:    
Royalties receivable (123,021) (77,565)
Prepaid expenses and other current assets (6,104) (23,032)
Accounts payable and accrued expenses 1,904 94,169
Deferred revenue (42,836) 49,746
Net cash used in operating activities (2,082,719) (2,071,060)
Cash flows from investing activities:    
Purchases of fixed assets (65,282) (11,663)
Net cash used in investing activities (65,282) (11,663)
Cash flows from financing activities:    
Net proceeds from issuances of common stock and warrants and exercise of options and warrants 5,770,545 3,314,292
Net cash provided by financing activities 5,770,545 3,314,292
Net increase in cash and cash equivalents 3,622,544 1,231,569
Cash and cash equivalents at beginning of year 2,969,416 1,737,847
Cash and cash equivalents at end of year $ 6,591,960 $ 2,969,416